EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

P38α deficiency alleviates myocardial ischemia/reperfusion injury by stabilizing c‑Myc to inhibit ferroptosis

Xiaohu Ouyang, Shuxin Song, Yalan Dong, Mi Xiang, Liangqingqing Yin, Xunxun Wang, Yan Ma, Yating Lu, Yaxuan Qi, Qingrui Nong, Hao Chen, Ruonan Yu und 4 weitere

Basic Research in Cardiology · 2026

DOI: 10.1007/s00395-026-01205-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic Research in Cardiology, 2026. Verfasst von Xiaohu Ouyang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technol…. Hauptthemen laut MEDLINE: Ferroptosis, Myocardial Reperfusion Injury, Mitogen-Activated Protein Kinase 14, Proto-Oncogene Proteins c-myc. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundations of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial ischemia/reperfusion (I/R) injury constitutes a major clinical challenge in ischemic heart disease, and ferroptosis has been recognized as a core driver of cardiomyocyte death during reperfusion. However, the upstream regulatory network governing myocardial ferroptosis remains incompletely defined. The mitogen-activated protein kinase 14 (p38α, MAPK14) is a stress-activated kinase critically involved in cardiac pathophysiology, yet its role in I/R-induced ferroptosis remains unclear. Here, we report that p38α deficiency attenuates ferroptosis and protects against myocardial I/R injury by stabilizing c-Myc. Phosphorylated p38α (p-p38α) was significantly elevated in mouse hearts after I/R and in cardiomyocytes following oxygen-glucose deprivation/reperfusion (OGD/R). Cardiomyocyte-specific p38α knockout markedly reduced ferroptosis, myocardial infarct size, and cardiac dysfunction. Mechanistically, p-p38α interacts with c-Myc under I/R stress via key residues Arg291, Arg300, and Lys304 of c-Myc and promotes the recruitment of the E3 ubiquitin ligase STUB1, thereby enhancing ubiquitination at Lys51 (K51) of c-Myc and its proteasomal degradation. Loss of p38α stabilizes c-Myc protein and reverses this process. Furthermore, c-Myc acts as a transcriptional repressor of NCOA4, a core mediator of ferroptosis. I/R-induced downregulation of c-Myc relieves NCOA4 suppression, triggering iron overload, lipid peroxidation, and ferroptosis. Overexpression of c-Myc or inhibition of STUB1 or NCOA4 abolished the pro-ferroptotic effect of I/R. Pretreatment with the p38α inhibitor VX-745 recapitulated the cardioprotective effects by restoring the p38α/c-Myc/NCOA4 axis in vivo. Collectively, our findings identify the p38α/c-Myc/NCOA4 signaling axis as a regulatory cascade governing myocardial I/R-induced ferroptosis. These findings nominate the p38α/c-Myc/NCOA4 axis as a potential therapeutic target in myocardial I/R injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisMyocardial Reperfusion InjuryMitogen-Activated Protein Kinase 14Proto-Oncogene Proteins c-mycMyocytes, CardiacAnimalsMice, KnockoutMice, Inbred C57BLMiceMaleSignal TransductionDisease Models, AnimalPhosphorylation

Stichwörter der Autor:innen

FerroptosisMyocardial ischemia/reperfusion injuryNCOA4c-Mycp38α

Substanzen

Mitogen-Activated Protein Kinase 14Proto-Oncogene Proteins c-mycMyc protein, mouse

Autor:innen und Institutionen

  • Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
  • Russian-Chinese Education and Research Center of System Pathology, South Ural State University, Chelyabinsk, Russia.
  • Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. shsh689@126.com.
  • Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. desheng.hu@hust.edu.cn.
  • Wuhan (China-Romania) Belt and Road Joint Laboratory on Traditional Chinese Medicine, Wuhan, 430030, China. desheng.hu@hust.edu.cn.

Förderung

  • National Natural Science Foundations of China

Zitieren

APA

Ouyang, X., Song, S., Dong, Y., Xiang, M., Yin, L., Wang, X., Ma, Y., Lu, Y., Qi, Y., Nong, Q., Chen, H., Yu, R., Sarapultsev, A., Cheng, X., Luo, S., & Hu, D. (2026). P38α deficiency alleviates myocardial ischemia/reperfusion injury by stabilizing c‑Myc to inhibit ferroptosis. Basic Research in Cardiology. https://doi.org/10.1007/s00395-026-01205-5

Vancouver

Ouyang X, Song S, Dong Y, Xiang M, Yin L, Wang X, et al. P38α deficiency alleviates myocardial ischemia/reperfusion injury by stabilizing c‑Myc to inhibit ferroptosis. Basic Research in Cardiology. 2026. doi:10.1007/s00395-026-01205-5

BibTeX
@article{Ouyang2026,
  author = {Ouyang, Xiaohu and Song, Shuxin and Dong, Yalan and Xiang, Mi and Yin, Liangqingqing and Wang, Xunxun and Ma, Yan and Lu, Yating and Qi, Yaxuan and Nong, Qingrui and Chen, Hao and Yu, Ruonan and Sarapultsev, Alexey and Cheng, Xiang and Luo, Shanshan and Hu, Desheng},
  title = {P38α deficiency alleviates myocardial ischemia/reperfusion injury by stabilizing c‑Myc to inhibit ferroptosis},
  journal = {Basic Research in Cardiology},
  year = {2026},
  doi = {10.1007/s00395-026-01205-5}
}
Kostenlos starten →